Outcome of the Board meeting held on 03rd August 2026

03rd August 2026 To To The Corporate Relations Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroz Jeejeebhoy Towers, 25th Floor, Exchange Plaza, Dalal Street, Bandra Kurla Complex, Bandra (East), Mumbai- 400001 Mumbai - 400 051 Scrip Code - 543308 Symbol - KIMS ISIN: INE967H01025 ISIN: INE967H01025 Dear Sir/Madam, Sub: Outcome of Board Meeting held on 03rd August 2026 pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 1. Further to our Board Meeting intimation dated 28th July 2026, the Board of Directors, at their meeting held today, have considered, reviewed deliberated and approved the Unaudited (Standalone and Consolidated) financial results of the Company for the 01st quarter ended 30th June 2026 together with the Limited Review Reports in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, as reviewed by the Audit Committee and enclosed as Annexure-A; 2. Further the Board of Directors during the meeting: a) Has approved to advance any loan including any loan represented by a book debt, or give guarantee or provide security in respect of loan taken not exceeding Rs. 650 Crores (Rupees Six Hundred Fifty Crores) over and above the limits available under section 186 of the Companies Act 2013, to any subsidiaries or associate or joint venture or group entity of the Company in which any director is deemed to be interested under Section 185 of the Companies Act, 2013, subject to the approval of the Shareholders of the Company by way of special resolution in the ensuing General Meeting of the company; b) Approved the proposal for extending a loan of up to ₹25 crore (Rupees Twenty-Five Crores) to KIMS Hospital Enterprises Private Limited, a material subsidiary of the Company, in accordance with the provisions of the Companies Act, 2013 and other applicable laws; c) Considered and approved the DRAFT O&M agreement and Call Option Agreement as tabled before the board of directors with Golden Lan Solutions Private Limited and Sarwottam Healthcare Private Limited. The requisite SEBI disclosures will be intimated at the time of execution the said definitive agreements accordingly. Further, the financial results are also available on the website of the Company at https://www.kimshospitals.com/investors/Disclosures under Regulation 46 of SEBI (LODR) Regulations, 2015/ Financial Information/ Financial Result and on the websites of BSE Ltd and National Stock Exchange of India Ltd viz. www.bseindia.com and www.nseindia.com, respectively. Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com CIN: L55101TG1973PLC040558 Further, the financial results will also be published in the newspaper as per the requirement and in the format prescribed under SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Board Meeting Commenced at : 12.15 P.M. Board Meeting Concluded at : 04: 15 P.M This is for your information and records. Thanking you, For Krishna Institute of Medical Sciences Limited Nagajayanthi J.R Company Secretary & Compliance Officer Enclosed: As above Krishna Institute of Medical Sciences Limited D.No.: 1-8-31/1, Minister Road, Secunderabad - 500 003, Telangana, India Phone: +91 40 4488 5000/4488 5184 | Fax: +91-40-27840980 | kimshospitals.com CIN: L55101TG1973PLC040558 S.R. BATL& IASSBOCOIATIES LLP TToHtEh SPKYVI E“WN O1R0T H LoBBY" Survey No. 83/1, Raidurgam Chartered Accountants Hyderabad - 500 032, India Tel : +91 40 6141 6000 Independent Auditor’s Review Report on the Quarterly Unaudited Standalone Financial Results of Krishna Institute of Medical Sciences Limited, Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Krishna Institute of Medical Sciences Limited 1. We have reviewed the accompanying statement of unaudited standalone financial results of Krishna Institute of Medical Sciences Limited (the “Company”) for the quarter ended June 30, 2026 (the “Statement™) attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations™). The Company’s Management is responsible for the preparation of the Statement in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) “Interim Financial Reporting™ prescribed under Section 133 oft he Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Statement has been approved by the Company’s Board ofD irectors. Our responsibility is to express a conclusion on the Statement based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standards (‘Ind AS’) specified under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For S.R. BATLIBOI & ASSOCIATES LLP Chartered Accountants ICAI Firm regjstPjtion number:101049W/E300004 (D ealibiniln per Mitesh K Parikh Partner Membership No.: 225333 UDIN: 262253332 klWN 8Ly Place: Hyderabad Date: August 03, 2026 S.R. Batlibol & Assoclates LLP,a Limited Liabiity Partnerwsithh iLLpP Identity No. AAB-4295 Regd. Offi:c 2e2 , Camac Street, Block ‘B, 3rd Floor, Kolkata-700106 Krishn Institute of Medical Seiences Limited Corporate Identity number : L53101 TG1 973PLC040SSS Registered office : 1-8-31/1, Ministers road, Secunderabad, 500003, Telangana, India Website: wwvw kimshospitals com, Email: CS@kimshospitals com, Tel: 040 7122 5000 Statement of Unaudited Standalone Financial Results for the quarter ended 30 June 2026 (Rupees in millions) Quarter ended Vear ended EIRITETS 1-Mar26 Seduns 31-Mar-26 (Unaudited) (Audited) (Unaudited) (Audited) (Refer note 3) () Revenue from operations 4836 4562 3734 17015 [(Tbo)t aOlt hIern coimneco me S307 a1 876 381 52 62 755 86 16 2 [Expenses (a) Purchase of medical consumables, drugs and surgical instruments. 999 910 781 3,468 (b) Increase in inventories of medical consumables, drugs and surgical instruments. (39) (@) (23)] (135)] (c) Employee benefis expense 819 720 652 2907 (&) Othr expenses 1845 1631 1319 60% (c)Finance costs 328 268 125 787 () Depreciation and amortsation expenses 2 255 175 861 [Showing first 8,000 characters — download PDF for full document]